NEW YORK (GenomeWeb) – Investment firm Pittsburgh Life Sciences Greenhouse (PLSG) announced on Thursday that it has made a roughly $100,000 investment in Ariel Precision Medicine, which is developing genetic tests for chronic diseases.
Already have a GenomeWeb or 360Dx account?Login Now.
Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.
The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.
Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.
In Nature this week: ash dieback disease fungal genome, and more.
This webinar will highlight a comprehensive end-to-end solution for precision care in oncology, comprising sample acquisition through to sequencing and analysis, treatment recommendations, and follow-through.